ClinicalTrials.Veeva
Menu

Find clinical trials for Diabetes in Taipei City

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Diabetes Mellitus
Type 2 Diabetes Mellitus
Type 1 Diabetes Mellitus
Diabetic Foot
Foot Ulcer
Ulcer
Obesity

Diabetes trials near Taipei City, TWN:

Locations recently updated

A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease

The purpose of this study is to assess the safety and efficacy (including durability) of up to 2 REACT injections given 3 months (+30 days) apart and...

Enrolling
Type 2 Diabetes Mellitus
Chronic Kidney Diseases
Biological: Renal Autologous Cell Therapy (REACT)
Procedure: Sham Comparator

Phase 3

Prokidney

Taipei, Taiwan and 46 other locations

To compare in diabetic patients eligible for percutaneous coronary intervention (PCI) with minimal exclusion criteria, the efficacy and safe...

Active, not recruiting
Diabetes
Coronary Artery Disease
Device: XIENCE Everolimus Eluting Coronary Stent System (XIENCE family)
Device: Abluminus DES+ Sirolimus Eluting Stent System (SES)
Concept Medical
Concept Medical

Taipei City, Taiwan and 89 other locations

with vehicle control in subjects with Wagner Grade 1 to Grade 2 diabetic foot ulcers. Baseline target ulcer size (\<16 cm2 vs ≥16 cm2 ) will...

Enrolling
Diabetes Mellitus
Diabetic Foot Ulcer
Drug: ENERGI-F703 GEL
Drug: ENERGI-F703 matched vehicle

Phase 3

Energenesis Biomedical

Taipei, Taiwan and 20 other locations

The purpose of the trial is to assess the efficacy and safety of tirzepatide to dulaglutide in participants with type 2 diabetes and increas...

Active, not recruiting
Type 2 Diabetes Mellitus
Drug: Tirzepatide
Drug: Dulaglutide

Phase 3

Lilly
Lilly

Taipei, Taiwan and 652 other locations

Status recently updated

This study compares 2 medicines for type 2 diabetes: semaglutide (new medicine) and a dummy medicine (placebo). Semaglutide will be tested t...

Enrolling
Active, not recruiting
Diabetes Mellitus, Type 2
Drug: Oral semaglutide
Drug: Placebo (semaglutide)

Phase 3

Novo Nordisk
Novo Nordisk

Taipei, Taiwan and 72 other locations

in improving blood sugar control in participants with type 2 diabetes (T2D) with inadequate glycemic control using metformin. The study will...

Enrolling
Type 2 Diabetes
Drug: Orforglipron
Drug: Dapagliflozin

Phase 3

Lilly
Lilly

Taipei, Taiwan and 77 other locations

double-blinded, vehicle-controlled, parallel, phase II study to evaluate the efficacy and safety of topical BB-101 for the treatment of diabetic...

Enrolling
Diabetic Foot Ulcer
Biological: BB-101

Phase 2

Blue Blood Biotech

Taipei, Taiwan

at Week 52 in participants with overweight or obesity without diabetes mellitus (Cohort A) and in participants with overweight or obesity wi...

Active, not recruiting
Type 2 Diabetes Mellitus
Overweight
Drug: Placebo
Biological: Maridebart Cafraglutide

Phase 2

Amgen
Amgen

Taipei, Taiwan and 78 other locations

Status recently updated

This study will look at how well CagriSema helps people with type 2 diabetes lower their blood sugar and body weight. CagriSema is a new inv...

Enrolling
Active, not recruiting
Type 2 Diabetes
Drug: Semaglutide
Drug: Cagrilintide

Phase 3

Novo Nordisk
Novo Nordisk

Taipei, Taiwan and 185 other locations

This study will look at how much CagriSema lowers blood sugar and body weight in people with type 2 diabetes. CagriSema is a new investigati...

Not yet enrolling
Diabetes Mellitus, Type 2
Drug: Cagrilintide
Drug: Semaglutide

Phase 3

Novo Nordisk
Novo Nordisk

Taipei, Taiwan and 160 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems